V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260010241 | 260006440 | 1.65 | null | Curative (C) | 2015-12-16 | 2016-01-17 | BENDAMUSTINE | N | N | 260022289 | CARBOPLATIN + PACLITAXEL |
| 260010242 | 260006440 | null | 69.2 | Disease modification (D) | 2018-12-30 | 2019-01-28 | EP | 2 | N | 260022289 | CISPLATIN + ETOPOSIDE |
| 260010243 | 260006440 | 1.78 | 76 | Palliative (P) | 2018-09-29 | 2018-10-13 | Pazopanib | N | N | 260022289 | CISPLATIN |
| 260010244 | 260006441 | 1.94 | null | Curative (C) | 2019-09-11 | 2019-09-25 | CISPLATIN + ETOPOSIDE | 02 | N | 260004266 | CISPLATIN + ETOPOSIDE |
| 260010245 | 260012520 | 1.64 | 87 | Adjuvant (A) | 2016-02-01 | 2016-02-10 | POUT TRIAL | 2 | N | 260005555 | CISPLATIN + VINORELBINE |
| 260010246 | 260006442 | 1.65 | 73.8 | Palliative (P) | 2017-12-28 | 2018-01-06 | Rituximab | N | N | 260006315 | RITUXIMAB |
| 260010247 | 260006442 | null | null | Curative (C) | null | 2017-08-09 | 111 Trial (formerly BEP 111) | null | null | 260006315 | CARBOPLATIN + ETOPOSIDE |
| 260010248 | 260006442 | 1.56 | null | Curative (C) | 2013-12-08 | 2013-12-15 | FEC 60 or 75 | N | N | 260006315 | CISPLATIN + PEMETREXED |
| 260010249 | 260017502 | 1.68 | 75.5 | Curative (C) | 2017-08-11 | 2017-08-16 | GEMCARBO | 1 | N | 260016873 | RITUXIMAB |
| 260010250 | 260017502 | 1.7 | null | null | 2016-09-16 | 2016-10-11 | Cisplatin + Radiotherapy | N | null | 260016873 | TRIAL |
| 260010251 | 260017502 | 1.65 | 94.1 | Palliative (P) | 2016-11-30 | 2016-12-11 | Rituximab | 02 | Y | 260016873 | RITUXIMAB |
| 260010252 | 260015768 | 1.82 | null | Curative (C) | 2015-09-28 | 2015-09-29 | Rituximab (Maintenance) | N | N | 260010776 | RITUXIMAB |
| 260010253 | 260012523 | null | 80.8 | Curative (C) | null | 2018-05-26 | Rituximab | null | N | 260010811 | RITUXIMAB |
| 260010254 | 260006445 | 1.7 | 90 | Disease modification (D) | 2016-02-25 | 2016-03-31 | Rituximab | null | null | 260010846 | RITUXIMAB |
| 260010255 | 260006446 | 1.82 | 87.6 | Curative (C) | null | 2018-01-27 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260010847 | RITUXIMAB |
| 260010256 | 260006448 | 1.68 | 81.4 | Curative (C) | 2014-02-20 | 2014-03-11 | Rituximab | 2 | N | 260010859 | RITUXIMAB |
| 260010257 | 260006449 | 1.81 | 70 | Adjuvant (A) | 2016-02-22 | 2016-09-14 | Rituximab | N | N | 260010921 | RITUXIMAB |
| 260010258 | 260006449 | 1.77 | 69.4 | Not known (9) | 2016-05-11 | 2016-05-12 | Rituximab (Maintenance) | N | N | 260010921 | RITUXIMAB |
| 260010259 | 260012527 | 1.75 | 83 | Palliative (P) | 2017-01-14 | 2017-01-14 | Rituximab | 02 | N | 260010969 | RITUXIMAB |
| 260010260 | 260006452 | 1.72 | 98 | Disease modification (D) | 2016-07-15 | 2016-08-12 | Rituximab | 02 | N | 260010974 | RITUXIMAB |
| 260010261 | 260006452 | 1.67 | 91.7 | Palliative (P) | 2015-08-04 | 2015-08-11 | Rituximab | 02 | N | 260010974 | RITUXIMAB |
| 260010262 | 260006453 | 1.69 | 90.7 | Palliative (P) | 2016-06-11 | 2017-01-08 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260011031 | RITUXIMAB |
| 260010263 | 260006454 | 0 | 66 | Palliative (P) | 2016-01-06 | 2016-03-10 | Rituximab | N | N | 260011163 | RITUXIMAB |
| 260010264 | 260012530 | null | 84.7 | Disease modification (D) | 2013-11-08 | 2013-11-09 | Rituximab (Maintenance) | N | N | 260011200 | RITUXIMAB |
| 260010265 | 260006455 | null | 101.8 | Adjuvant (A) | 2018-08-13 | 2018-08-15 | Rituximab | N | N | 260011246 | RITUXIMAB |
| 260010266 | 260012531 | null | 55.1 | Curative (C) | 2014-02-26 | 2014-03-04 | Rituximab (Maintenance) | 02 | N | 260011282 | RITUXIMAB |
| 260010267 | 260015771 | 1.63 | 75.5 | Curative (C) | 2016-03-20 | 2016-03-23 | Rituximab | 02 | Y | 260011308 | RITUXIMAB |
| 260010268 | 260006456 | 1.75 | 100.4 | Curative (C) | 2017-03-30 | 2017-04-03 | Rituximab | 02 | N | 260011310 | RITUXIMAB |
| 260010269 | 260006457 | 1.79 | null | Palliative (P) | 2013-11-20 | 2013-12-13 | Rituximab (Maintenance) | 02 | N | 260011310 | RITUXIMAB |
| 260010270 | 260006458 | 1.63 | null | Curative (C) | 2013-07-20 | 2014-01-08 | Rituximab | N | N | 260011322 | RITUXIMAB |
| 260010271 | 260006458 | 0 | 91 | Neo-adjuvant (N) | 2014-09-04 | 2014-09-11 | Rituximab | N | N | 260011322 | RITUXIMAB |
| 260010272 | 260006459 | 1.77 | 46.5 | Palliative (P) | 2016-05-30 | 2016-05-30 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 260011412 | RITUXIMAB |
| 260010273 | 260015774 | null | null | Curative (C) | 2016-10-03 | 2017-04-17 | Rituximab | N | N | 260011439 | RITUXIMAB |
| 260010274 | 260017503 | 1.8 | 99 | Palliative (P) | 2018-06-17 | 2018-08-12 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 260011542 | RITUXIMAB |
| 260010275 | 260006460 | 1.79 | 68.4 | Disease modification (D) | null | 2016-11-26 | Rituximab (SUBCUTANEOUS Maintenance) | null | N | 260011543 | RITUXIMAB |
| 260010276 | 260006460 | 0 | null | Curative (C) | 2015-05-04 | 2015-05-11 | Rituximab | null | null | 260011543 | RITUXIMAB |
| 260010277 | 260012537 | 1.6 | 0 | Disease modification (D) | 2016-04-17 | 2016-10-22 | Rituximab (Maintenance) | N | N | 260011573 | RITUXIMAB |
| 260010278 | 260006463 | 1.83 | 65.3 | Radical (R) | 2014-03-28 | 2014-03-28 | Rituximab | 02 | N | 260011628 | RITUXIMAB |
| 260010279 | 260006463 | 1.74 | 89.9 | Adjuvant (A) | 2018-08-03 | 2018-08-03 | Rituximab | 02 | N | 260011628 | RITUXIMAB |
| 260010280 | 260006464 | 1.6 | 59.4 | null | 2016-12-14 | 2016-12-16 | Rituximab | 2 | N | 260011668 | RITUXIMAB |
| 260010281 | 260006465 | 1.7 | 93 | Palliative (P) | 2014-09-24 | 2014-10-23 | Rituximab | N | N | 260011687 | RITUXIMAB |
| 260010282 | 260012540 | 1.57 | 81 | Not known (9) | 2013-09-24 | 2013-09-28 | Rituximab | N | N | 260011735 | RITUXIMAB |
| 260010283 | 260012540 | null | null | null | 2015-12-19 | 2015-12-25 | Rituximab | 2 | N | 260011735 | RITUXIMAB |
| 260010284 | 260006466 | 1.78 | null | null | null | 2016-10-13 | Rituximab | N | N | 260011800 | RITUXIMAB |
| 260010285 | 260006466 | 1.81 | 97 | Palliative (P) | 2017-05-11 | 2017-10-29 | Rituximab | N | N | 260011800 | RITUXIMAB |
| 260010286 | 260006467 | 1.65 | 70.7 | Curative (C) | 2015-12-06 | 2016-05-23 | Rituximab | N | N | 260011994 | RITUXIMAB |
| 260010287 | 260015779 | 1.75 | null | Disease modification (D) | 2016-03-27 | 2016-03-29 | Rituximab (Maintenance) | N | N | 260012042 | RITUXIMAB |
| 260010288 | 260015779 | 1.81 | 97.3 | Curative (C) | 2014-06-13 | 2014-06-25 | Rituximab (Maintenance) | N | N | 260012042 | RITUXIMAB |
| 260010289 | 260006470 | null | null | Disease modification (D) | 2014-05-27 | 2014-05-31 | Rituximab (Maintenance) | 2 | N | 260012051 | RITUXIMAB |
| 260010290 | 260006471 | null | 90 | Disease modification (D) | 2018-02-09 | 2018-02-27 | Rituximab | 02 | N | 260012100 | RITUXIMAB |